Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL289199 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL120683 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL20267799 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL238123 | 0.97 | — | — | |
| SCHEMBL95867 | 0.94 | — | — | |
| Water SCHEMBL29080231 | 0.90 | — | — | |
| SCHEMBL9193186 | 0.90 | SMN1; SMN2 (0.35) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Chloroform SCHEMBL10841676 | 0.88 | SMN1; SMN2 (0.30) | SMN1; SMN2 | |
| SCHEMBL30569675 | 0.83 | — | — | |
| SCHEMBL30899237 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116640798-A | Salt stress analysis method of alfalfa gene promoter | 鲁东大学 | 2023-08-25 | — | — | CN | claimed |
| WO-2024054768-A2 | BRASSICA CYTOPLASMIC MALE STERILITY (CMS) FERTILITY RESTORER NUCLEIC ACIDS, MARKERS, METHODS, AND ZYGOSITY ASSAYS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| CN-116640798-A | Salt stress analysis method of alfalfa gene promoter | 鲁东大学 | 2023-08-25 | — | — | CN | disclosed |
| US-11319599-B2 | Genetic loci associated with reproductive growth phenotypes in soybean and methods of use | PIONEER HI-BRED INTERNATIONAL, INC. | 2022-05-03 | — | — | US | disclosed |
| US-11225668-B2 | Modified FRT recombination site libraries and methods of use | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2022-01-18 | — | — | US | disclosed |
| US-20210348179-A1 | COMPOSITIONS AND METHODS FOR REGULATING GENE EXPRESSION FOR TARGETED MUTAGENESIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-11-11 | — | — | US | disclosed |
| US-11028453-B2 | QTLs associated with and methods for identifying lodging resistance in soybean | PIONEER HI-BRED INTERNATIONAL, INC. | 2021-06-08 | — | — | US | disclosed |
| US-10709727-B2 | Antiviral drugs | IDAC THERANOSTICS, INC. (JP) | 2020-07-14 | — | — | US | disclosed |
| US-10577666-B2 | Compositions associated with soybean reproductive growth and methods of use | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2020-03-03 | — | — | US | disclosed |
| US-20190194673-A1 | MODIFIED FRT RECOMBINATION SITE LIBRARIES AND METHODS OF USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2019-06-27 | — | — | US | disclosed |
| EP-0587798-A4 | INSECTICIDAL PROTEINS AND METHOD FOR PLANT PROTECTION. | DOWELANCO (US) | 1995-04-19 | — | — | EP | disclosed |
| US-5399496-A | Industrial production of polypeptides | HOFFMAN-LAROCHE INC. (US) | 1995-03-21 | — | — | US | disclosed |
| CN-1095723-A | Nucleic acid preparation method and nucleic acid Ganoderma oral liquid thereof | PAN GUANGWAN (CN) | 1994-11-30 | — | — | CN | disclosed |
| EP-0587798-A1 | INSECTICIDAL PROTEINS AND METHOD FOR PLANT PROTECTION | DOWELANCO (US) | 1994-03-23 | — | — | EP | disclosed |
| EP-0133473-B1 | In vivo labelling of polynucleotide sequences | ENZO BIOCHEM INC (US) | 1994-03-23 | — | — | EP | disclosed |
| WO-1992021753-A1 | INSECTICIDAL PROTEINS AND METHOD FOR PLANT PROTECTION | DOWELANCO (US) | 1992-12-10 | — | — | WO | disclosed |
| US-4994373-A | Hybridization, labeling | ENZO BIOCHEM, INC. (US) | 1991-02-19 | — | — | US | disclosed |
| US-4987065-A | GENETIC ENGINEERING | ENZO BIOCHEM, INC. (US) | 1991-01-22 | — | — | US | disclosed |
| US-4503218-A | BACTERICIDE | E. R. SQUIBB & SONS, INC. (US) | 1985-03-05 | — | — | US | disclosed |
| EP-0133473-A2 | In vivo labelling of polynucleotide sequences | ENZO BIOCHEM, INC. (US) | 1985-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10709727-B2 | Antiviral drugs | DOCK2, DOCK11, HAVCR2 | LMNA 2107/4885ALDH1A1 2649/4885HSD17B10 719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.